CD44 and pancreatic adenocarcinoma: Thus, whether pancreatic adenocarcinoma tumors arise from different CSC/progenitor populations enriched through selection of alternative cell surface/functional phenotypes (i.e. CD44/CD24, CD133, or ALDH) or common CSC/progenitor populations exist that expresses shared, “universal” TIC markers remains unclear.